Researcher, Douglas Institute
serge_dot_gauthier_At_mcgill_dot_ca |
2013
Arrighi H. M., Gelinas I., McLaughlin T. P., Buchanan J., Gauthier S. (2013). Longitudinal changes in functional disability in Alzheimer's disease patients, Int Psychogeriatr, 25(6), 929-37. Find out more.
Cheewakriengkrai L., Gauthier S. (2013). A 10-year perspective on donepezil, Expert Opin Pharmacother, 14(3), 331-8. Find out more.
Clement F., Gauthier S., Belleville S. (2013). Executive functions in mild cognitive impairment: emergence and breakdown of neural plasticity, Cortex, 49(5), 1268-79. Find out more.
Dubois B., Gauthier S., Cummings J. (2013). The utility of the new research diagnostic criteria for Alzheimer's disease, Int Psychogeriatr, 25(2), 175-7. Find out more.
Forlini C., Gauthier S., Racine E. (2013). Should physicians prescribe cognitive enhancers to healthy individuals?, CMAJ, 185(12), 1047-50. Find out more.
Gauthier S. (2013). Les traitements pharmacologiques actuels de la maladie d’Alzheimer et perspectives futures. Le défi de la maladie d’Alzheimer : Synergies franco-québécoises, , 89-92.
Gauthier S., Leuzy A., Racine E., Rosa-Neto P. (2013). Diagnosis and management of Alzheimer's disease: Past, present and future ethical issues, Prog Neurobiol. Find out more.
Gauthier S., Molinuevo J. L. (2013). Benefits of combined cholinesterase inhibitor and memantine treatment in moderate-severe Alzheimer's disease, Alzheimers Dement, 9(3), 326-31. Find out more.
Gauthier S., Robillard A., Cohen S., Black S., Sampalis J., Colizza D., de Takacsy F., Schecter R. (2013). Real-life effectiveness and tolerability of the rivastigmine transdermal patch in patients with mild-to-moderate Alzheimer's disease: the EMBRACE study, Curr Med Res Opin, 29(8), 989-1000. Find out more.
Gauthier S., Rosa-Neto P. (2013). Dementia: Disclosure of results to participants in dementia research, Nat Rev Neurol. Find out more.
Herrmann N., Gauthier S., Boneva N., Lemming O. M. (2013). A randomized, double-blind, placebo-controlled trial of memantine in a behaviorally enriched sample of patients with moderate-to-severe Alzheimer's disease, Int Psychogeriatr, 25(6), 919-27. Find out more.
Holthoff V., Ferris S., Gauthier S., Ihl R., Robert P., Winblad B., Sternberg K., Tennigkeit F. (2013). Memantine effects measured with the Relevant Outcome Scale for Alzheimer's disease in an open-label, single-arm, multicenter clinical study, Int J Geriatr Psychiatry, 28(2), 164-72. Find out more.
Leuzy A., Rosa-Neto P., Gauthier S. (2013). Revising the diagnostic criteria for Alzheimer’s disease: the use of biomarkers and attendant ethical implications, Int J Sci Society, 4.
Masellis M., Sherborn K., Rosa-Neto P., Sadovnick D. A., Hsiung G. Y., Black S. E., Prasad S., Williams M., Gauthier S. (2013). Early-onset dementias: diagnostic and etiological considerations, Alzheimers Res Ther, 5(Suppl 1), S7. Find out more.
Palmour N., Vanderbyl B. L., Zimmerman E., Gauthier S., Racine E. (2013). Alzheimer's Disease Dietary Supplements in Websites, HEC Forum. Find out more.
Parent M. J., Bedard M. A., Aliaga A., Minuzzi L., Mechawar N., Soucy J. P., Schirrmacher E., Kostikov A., Gauthier S., Rosa-Neto P. (2013). Cholinergic Depletion in Alzheimer's Disease Shown by [(18) F]FEOBV Autoradiography, Int J Mol Imaging, 2013, 205045. Find out more.
Patterson C., Gauthier S. (2013). Diagnosis and treatment of dementia: the fourth canadian consensus conference, Alzheimers Res Ther, 5(Suppl 1), S1. Find out more.
Poirier J., Gauthier S. (2013). Ich habe mich selbst verloren, .
Rive B., Gauthier S., Costello S., Marre C., Francois C. (2013). Synthesis and comparison of the meta-analyses evaluating the efficacy of memantine in moderate to severe stages of Alzheimer's disease, CNS Drugs, 27(7), 573-82. Find out more.
Rowley J., Fonov V., Wu O., Eskildsen S. F., Schoemaker D., Wu L., Mohades S., Shin M., Sziklas V., Cheewakriengkrai L., Shmuel A., Dagher A., Gauthier S., Rosa-Neto P., Alzheimer's Disease Neuroimaging Initiative (2013). White matter abnormalities and structural hippocampal disconnections in amnestic mild cognitive impairment and Alzheimer's disease, PLoS One, 8(9), e74776. Find out more.